Filing Details
- Accession Number:
- 0001415889-25-007738
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-11 20:17:08
- Reporting Period:
- 2025-03-07
- Filing Date:
- 2025-03-11
- Accepted Time:
- 2025-03-11 20:17:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1722964 | Y-Mabs Therapeutics Inc. | YMAB | Pharmaceutical Preparations (2834) | 474619612 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1948795 | J Michael Rossi | C/O Y-Mabs Therapeutics, Inc. 202 Carnegie Center, Suite 301 Princeton NJ 08540 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-07 | 3,917 | $5.20 | 137,083 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.